Genomics of Colon Cancer Disparities to Identify Markers for Patient Screening and Treatment

Samir Agarwal, M.D., F.A.C.S. and Norman Lee, Ph.D., Investigators
December 18, 2013

To identify gene expression and splice variation differences in colon cancer between African-American (AA) and Caucasian-American (CA) patients in an aim to investigate differences in the natural progression of the disease between the two racial populations.

The identification of differential splice variants represents a novel avenue for the development of targeted therapeutics and/or cancer markers to predict patient responsiveness to cancer therapeutics.